{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:52:24Z","timestamp":1767919944766,"version":"3.49.0"},"reference-count":9,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T00:00:00Z","timestamp":1499040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T00:00:00Z","timestamp":1499040000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T00:00:00Z","timestamp":1499040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Two gene variants provide different levels of protection against sleeping sickness, but this comes with an increased risk of developing chronic kidney disease.<\/jats:p>","DOI":"10.7554\/elife.29056","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T11:00:10Z","timestamp":1499079610000},"source":"Crossref","is-referenced-by-count":7,"title":["The double-edged sword of evolution"],"prefix":"10.7554","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7208-5707","authenticated-orcid":true,"given":"Etty","family":"Kruzel-Davila","sequence":"first","affiliation":[{"name":"Department of Nephrology, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0900-3406","authenticated-orcid":true,"given":"Karl","family":"Skorecki","sequence":"additional","affiliation":[{"name":"Department of Medical and Research Development, Rambam Heath Care Campus, Haifa, Israel"},{"name":"Rappaport Faculty of Medicine, Technion \u2013 Israel Institute of Technology, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4374","published-online":{"date-parts":[[2017,7,3]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-3024.2011.01287.x","article-title":"Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections","volume":"33","author":"Bucheton","year":"2011","journal-title":"Parasite Immunology"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"e25461","DOI":"10.7554\/eLife.25461","article-title":"APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis","volume":"6","author":"Cooper","year":"2017","journal-title":"eLife"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"e1004469","DOI":"10.1371\/journal.ppat.1004469","article-title":"Unravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNF\u03b1 are associated with subsequent disease development","volume":"10","author":"Ilboudo","year":"2014","journal-title":"PLoS Pathogens"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrmicro3298","article-title":"The molecular arms race between African trypanosomes and humans","volume":"12","author":"Pays","year":"2014","journal-title":"Nature Reviews Microbiology"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"E2130","DOI":"10.1073\/pnas.1400699111","article-title":"Evolution of the primate trypanolytic factor APOL1","volume":"111","author":"Thomson","year":"2014","journal-title":"PNAS"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Human Genetics"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nature12516","article-title":"Mechanism of Trypanosoma brucei gambiense resistance to human serum","volume":"501","author":"Uzureau","year":"2013","journal-title":"Nature"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/29056\/elife-29056-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/29056\/elife-29056-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/29056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:58:41Z","timestamp":1697072321000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/29056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,3]]},"references-count":9,"alternative-id":["10.7554\/eLife.29056"],"URL":"https:\/\/doi.org\/10.7554\/elife.29056","archive":["CLOCKSS"],"relation":{},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,3]]},"article-number":"e29056"}}